Tag: cellular therapies

March 1, 2018

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results

Intra-Cellular Therapies (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced...
April 28, 2017

Sorrento's Cell Therapy Subsidiary Acquires Virttu

Sorrento Therapeutics announced its cell therapy subsidiary TNK Therapeutics completed the acquisition of Virttu Biologics.
March 29, 2017

VistaGen Obtains European Patent For AV-101

VistaGen Therapeutics announced the European Patent Office issued a notice of intention to grant the company's European patent application for...